The novel use of mu-opioid receptor antagonism for the treatment of refractory pruritus in Kyrle's disease

Int J Womens Dermatol. 2019 Oct 16;5(5):389-390. doi: 10.1016/j.ijwd.2019.09.003. eCollection 2019 Dec.

¹ The Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, United States.

No abstract available

Keywords: Acquired perforating dermatosis; Butorphanol; Kyrle’s disease; Mu-antagonist; Opioid antagonist; Refractory pruritus; Uremic pruritus.